Tasigna advantage in treatment of newly diagnosed chronic myeloid leukemia: results of «Novartis research»
.
Saved in:
| Main Author: | article Editorial |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2022-11-01
|
| Series: | Онкогематология |
| Online Access: | https://oncohematology.abvpress.ru/ongm/article/view/787 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Newly diagnosed acute myeloid leukemia in unfit patients: 2026 treatment algorithms
by: Naseema Gangat, et al.
Published: (2025-08-01) -
Fatal Disseminated Mucormycosis by Cunninghamella in Newly Diagnosed Acute Myeloid Leukemia: Case Report and Diagnostic Challenges
by: Sebastián González-Valdés, et al.
Published: (2025-04-01) -
The treatment of chronic myeloid leukemia, data from Gujarat Cancer and Research Institute, Ahmedabad
by: Sandip A Shah
Published: (2013-01-01) -
Acute Myeloid Leukemia with NUP98: : LNP1 Fusion Mimicking Chronic Myeloid Leukemia
by: Haiyang Wang, et al.
Published: (2025-06-01) -
METABOLIC STATE OF BLOOD LYMPHOCYTES IN CHRONIC MYELOID LEUKEMIA AND CHRONIC LYMPHOID LEUKEMIA
by: O. V. Smirnova, et al.
Published: (2014-07-01)